All data are based on the daily closing price as of July 4, 2025
j

JW Pharmaceutical

001060.KO
16.69 USD
-0.25
-1.48%

Overview

Last close
16.69 usd
Market cap
380.05M usd
52 week high
26.70 usd
52 week low
13.57 usd
Target price
24.96 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.7156
Price/Book Value
1.6196
Enterprise Value
411.75M usd
EV/Revenue
0.7838
EV/EBITDA
5.348

Key financials

Revenue TTM
531.46M usd
Gross Profit TTM
238.31M usd
EBITDA TTM
71.47M usd
Earnings per Share
N/A usd
Dividend
0.33 usd
Total assets
414.62M usd
Net debt
N/A usd

About

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.
  • Symbol
    001060.KO
  • Exchange
    KO
  • Isin
    KR7001060003
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Young-Sub Shin
  • Headquarter
    Gwacheon-si
  • Web site
    https://www.jw-pharma.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top